Harriet Alexander Sydney Morning Herald. Published: October 14, 2015 6:34PM Every minute of the night and day, for decades, Jaswir Grewal was in pain. The constant ache in his back forced him to leave his jobs as a mechanic and banana grower. The pain troubled his sleep, made him irritable with his wife, depressed about his […]
Northridge, CA and Cambridge, United Kingdom, 7 October 2015 Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a medical device company specializing in the treatment of wounds and skin defects, today announced it has received CE Mark authorization to market in Europe that will allow it to define and target its autologous cell suspension technology for […]
Link here.
Northridge, CA and Cambridge, United Kingdom, 5 October 2015 Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced approval from the U.S. Food and Drug Administration (FDA) for the expansion of its Compassionate Use Investigational Device Exemption (IDE) program for ReCell®. The IDE […]
SEA: NZX and Media Release 30 September 2015. NZX link here. SeaDragon raises $10.009 million via rights offer and shortfall bookbuild, and additional placement Successful capital raising at $0.008 per share facilitates the completion of the company’s new Omega-3 fish oil refinery. New Zealand’s leading refiner and blender of high-quality fish oils SeaDragon Limited (NZX:SEA) today […]
Link here. 30 September 2015. Highlights: BARDA contract commits initial USD16.9m to support Avita’s FDA approval trial for treatment of thermal burn injuries and procure 5000-plus ReCell® devices. Contract also establishes a strategic, Avita-managed stockpile for ReCell® devices to supply nationally. A further potential to receive USD37M in contract options to support additional clinical trials and […]
30 September 2015. Link here. ..Three independent studies support the positive impact of Smartinhaler™ Platform in paediatric asthma. ..144% increase in adherence and 37% reduction in oral steroids indicating reduced severe exacerbations. ..Data disclosed at prestigious European Respiratory Congress in Amsterdam. ..Adds to data on Adherium’s SmartInhaler published in Lancet Respiratory Medicine Adherium Limited (ASX: ADR), […]
DUBLIN, Ireland, Sept. 29, 2015 (GLOBE NEWSWIRE). Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced receipt of US$3.2 million in cash under the Australian Federal Government’s Research and Development (R&D) Tax Incentive program. This program provides a 45 percent refundable tax offset for qualifying R&D in Australia, where Nexvet conducts its drug discovery […]
18 September, link here. Rex Bionics Plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, notes two recent legal settlements — awarding funding for the purchase of a REX robot and funding for Robot-Assisted Physiotherapy with REX. These developments help to establish an important principle – that individuals […]
DUBLIN, Ireland, Sept. 16, 2015 (GLOBE NEWSWIRE) — Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced it has secured a dedicated biologics manufacturing facility in Tullamore, Ireland. The transaction is supported by the Irish Government’s Department of Jobs, Enterprise & Innovation through IDA Ireland, their foreign investment agency. BioNua Limited, a wholly-owned subsidiary […]